This report is the third edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Scope
This 55-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
Reasons to Buy
Scope
This 55-page report gives important, expert insight you won’t find in any other source. 28 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
- Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking
Reasons to Buy
- Overview of M&A in the Pharma CMO Industry
- Detailed view of CDMO performance by number of deals completed from the publisher's Deals database
- Analysis of the M&A of specific manufacturing services
Table of Contents
- About the Publisher
- Executive Summary
- Players
- Trends
- Industry Analysis
- Objectives and Methodology
- Overview of M&A Activity 2018-2020
- Target Characteristics
- Acquirer Characteristics
- Geography
- Top Acquirers
- Segment Close-Ups of M&A Activity, 2018-2020
- API-Biologic
- API-Small Molecule
- Commercial Dose Manufacturing
- Analytical Services
- Packaging
- Deal Advisors
- Top Financial Advisors
- Top Legal Advisors
- Valuations
- Facility Acquisitions
- What It Means
- The Outlook for M&A
- API-Biologic Targets
- Past Predictions
- Value Chain
- Companies
- Appendix
- Methodology
- Bibliography
- Primary Research - Key Opinion Leaders
- Further Reading
- About the Authors
- Contact the Publisher
List of Tables
Table 1: CMO M&A Trends, 2018-2020
Table 2: Company Acquisitions by Target Service Offering and Year, 2018-2020
Table 3: Company Acquisitions by Target Service Offering and Target Ownership, 2018-2020
Table 4: Company Acquisitions by Target Service Offering and Deal Region, 2018-2020
Table 5: Company Acquisitions by Target Service Offering and Acquirer Ownership, 2018-2020
Table 6: Services Deals with Known Transaction Value and Multiples, 2018-2020
Table 7: Facility Acquisitions by CMOs, 2018-2020
Table 8: Acquisitions by PE Firms, 2018-2020
Table 9: Potential Targets: API-Biologic (Protein & Peptide) Service Providers
Table 10: Potential Targets: API-Biologic (Gene and Cell Therapy) Service Providers
Table 11: Company Acquisitions and Private Equity Deals, 2018-2020
Table 12: Further Reading
List of Figures
Figure 1: Leading Acquirers in the Global Pharma CMO Industry, 2018-2020
Figure 2: Top M&A Trends in the CMO Industry, 2018-2020
Figure 3: CMO M&A Activity, 2018-2020
Figure 4: CMO M&A Activity by Year, 2018-2020
Figure 5: Company Acquisitions by Target Service Offering, 2018-2020
Figure 6: Company Acquisitions by Target Ownership, 2018-2020
Figure 7: Acquisition Targets by Sophistication of Capabilities
Figure 8: Number of Acquisitions 2018-2020 by Acquirer’s Core Business
Figure 9: Number of Acquisitions by Acquirer’s Ownership
Figure 10: Number of Acquisitions by Deal Country (Top Four), 2018-2020
Figure 11: Most Active Acquirers, 2018-2020
Figure 12: Dose Forms Manufactured by Acquired Dose Manufacturers, 2018-2020
Figure 13: Top Financial Advisors to Company Acquisitions, 2018-2020
Figure 14: Company Acquisition Top Legal Advisors, 2018-2020
Figure 15: Pharma CMO Facility Acquisitions, 2018-2020
Figure 16: The Contract Manufacturing Value Chain
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- AB BioTechnologies Inc
- ABL Lyon SAS
- ABS (Aus) Pty Ltd
- Absorption Systems LLC
- Abzena Ltd
- Ache Laboratorios Farmaceuticos SA
- ACS Dobfar SpA
- ADC Biotechnology Ltd
- Advent International Corp
- AGC Biologics Inc
- AGC Inc
- Akron Biotechnology LLC
- Alcaliber SA
- Alcami Corp
- Aldevron LLC
- Alliance Contract Pharma LLC
- ALS Ltd
- Altasciences Co Inc
- AmbioPharm Inc
- AMPAC Fine Chemicals LLC
- Ampersand Capital Partners
- Anjan Drug Pvt Ltd
- Aphena Pharma Solutions Inc
- AptarGroup Inc
- Arc Trinova Ltd
- Arcline Investment Management LP
- Ardena Holding NV
- Arena Pharmaceuticals GmbH
- As Produksjonslab AS
- Asahi Kasei Pharma Denmark A/S
- Ascendis Health Ltd
- AstraZeneca Plc
- Astro Bidco Ltd
- Aurisco Pharmaceutical Co Ltd
- Avaca Pharma
- Avanti Polar Lipids Inc
- Avara Pharmaceutical Services Inc
- Avista Capital Holdings LP
- Bain Capital Private Equity LP
- Bayer AG
- Benchmark Holdings PLC
- Berkshire Sterile Manufacturing Inc
- BGF Investments LP
- Bio V Pharma Inc
- BioAgilytix Labs LLC
- Bio-Concept Laboratories Inc
- Biocult BV
- BioDuro LLC
- Biogen Denmark Manufacturing ApS
- Bionova Scientific Inc
- BioScreen Testing Services Inc
- Biospring Partners
- BioVectra Inc
- Biovian Oy
- Bora Pharmaceuticals Co Ltd
- Bridgepoint Advisers, Ltd.
- Bridgewest Australia Holdings LLC
- BrightGene Bio-Medical Technology Co Ltd
- Bristol-Myers Squibb Co
- C.O.C. Farmaceutici Srl
- Cadila Healthcare Ltd
- Cambrex Corp
- Capua BioServices SpA
- Carlyle Asia Partners V LP
- Catalent Inc
- Cell and Gene Therapy Catapult
- CELLforCURE
- Cellix Bio Pvt Ltd
- Centrient Pharmaceuticals Netherlands BV
- Charles River Laboratories International Inc
- Charnwood Molecular Ltd
- ChemConnection BV
- Chemical Solutions Ltd
- CiToxLAB Group
- Civentichem LLC
- Claris Lifesciences Ltd
- Clean Cells SAS
- Clinigen Group Plc
- Cobepa SA
- Cobra Biologics Ltd
- Cognate BioServices Inc
- Concept Life Sciences Ltd
- Consort Medical Ltd
- Contract Pharmaceutical Services of Australia Pty Ltd
- Control Laboratory & Analysis SA
- Coripharma
- Corona Remedies Pvt Ltd
- Cosette Pharmaceuticals Inc
- Covance Inc
- Croda International Plc
- C-squared Pharma Sarl
- Curida AS
- CX Partners LLP
- Cytiva
- Dalton Pharma Services
- Danaher Corp
- Delpharm SAS
- Dhanuka Laboratories Ltd
- Dr. Reddy's Laboratories Ltd
- Echo Pharmaceuticals BV
- Elion Labs
- EQT IX Fund
- Escientia Life Science LLC
- Eubioco SA
- Eurofins Advinus Ltd
- Eurofins Scientific SE
- Euticals SpA
- Evotec SE
- EW Healthcare Partners
- Famar Health Care Services
- Fareva SA
- Farmaceutici Procemsa SpA
- Flamma SpA
- FPCI Capital Sante 2
- Frontage Laboratories Inc
- FTF Pharma Pvt Ltd
- Fujifilm Diosynth Biotechnologies USA Inc
- Fujifilm Holdings Corp
- FUJIFILM Toyama Chemical Co Ltd
- G&W Laboratories Inc
- Gamot API Pte Ltd
- General Atlantic LLC
- Genovis AB
- Genscript Biotech Corp
- GHO Capital Partners LLP
- GlaxoSmithKline Plc
- Gomti Life Sciences India Private Limited
- Goodwin Biotechnology Inc
- Granules-Biocause Pharmaceutical Co Ltd
- Great Point Partners, LLC
- H.I.G. Capital LLC
- Hebei Hejia Pharmaceutical Group Co Ltd
- Hikma Pharmaceuticals Plc
- Honeywood Ltd
- Horizon Discovery Group Plc
- Hubei Biocause Pharmaceutical Co Ltd
- Hycult Biotech BV
- Impopharma Canada Ltd
- Importfab Inc
- India Life Sciences Fund II
- India Life Sciences Fund III
- Industria Chimica Emiliana SpA
- Industria Farmaceutica Melcon do Brasil SA
- Infinity Laboratories
- Intas Pharmaceuticals Ltd
- Intermediate Capital Group Plc
- Investindustrial Growth
- IPCA Laboratories Ltd
- Iwaki & Co Ltd
- Iwaki Seiyaku Co Ltd
- Jiangsu Chengxin Pharmaceutical Co Ltd
- Jiangxi Fushine Pharmaceutical Co Ltd
- JSC Biocom
- JSFC Sistema
- Juniper Pharmaceuticals Inc
- Just Evotec Biologics Inc
- Kalexsyn Inc
- KBI Biopharma Inc
- Keensight Capital
- Kemp Proteins LLC
- Kirin Holdings Co Ltd
- Kohlberg & Company LLC
- Konsyl Pharmaceuticals Inc
- Kymos Pharma Services SL
- Kyowa CritiCare Co Ltd
- Kyowa Hakko Bio Co Ltd
- La Chandra Pharmalab Pvt Ltd
- Laboratorium fur Betriebshygiene GmbH
- LDO SpA
- Leonard Green & Partners LP
- LGM Pharma LLC
- LIVIA Corporate Development SE
- Lonza Group Ltd
- Lusomedicamenta - Sociedade Tecnica Farmaceutica, S.A
- Lyophilization Services of New England Inc
- Madison Dearborn Partners LLC
- Malgrat Pharma Chemicals, S.L.U.
- MaSTherCell SA
- Mercachem-Syncom Group
- Mercia Asset Management PLC
- Merck & Co Inc
- Mikart Inc
- Minaris Regenerative Medicine GmbH FKA apceth Biopharma GmbH
- Minaris Regenerative Medicine LLC
- Mitsubishi Chemical Holdings Corp
- Mitsubishi Tanabe Pharma Corp
- MolMed SpA
- MPI Research Inc
- Murli Krishna Pharma Pvt Ltd
- Naari Pharma Pvt Ltd
- Nanjing Hongjing Enterprise Management Consulting Co., Ltd.
- Naobios
- Natural Capsules Ltd
- Nautic Partners, LLC
- neo ALA Co Ltd
- Nevu Sp Zoo
- New England Peptide Inc
- New Zealand Pharmaceuticals Ltd
- Nexgen Pharma Inc
- Nipro Pharma Corp
- Nitin Lifesciences Ltd
- Novartis AG
- Novast Holdings Ltd
- Nx Phase Capital Inc.
- Olon Ricerca Biosciences LLC
- Olon SpA
- Opocrin SpA
- Orchid Pharma Ltd
- Orifarm Group A/S
- Oxford Genetics Ltd
- Pace Analytical Services LLC
- PAMA Holding Sarl
- Paragon Bioservices Inc
- Patheon NV
- Patheon Viral Vector Services
- PCI Pharma Services
- Peptides International Inc
- Permira Advisers LLP
- Pfizer Inc
- PharmaBlock Sciences Nanjing Inc
- Pharmaceutical Associates Inc
- Pharmaceutical Packaging Professionals Pty Ltd
- Pharmaron Beijing Co Ltd
- Pharmatis SAS
- PharmaZell GmbH
- Pihex - Investimentos Imobiliarios, Lda
- Pilatus Pharma Ltd
- Piramal Pharma Solutions Inc
- Pisgah Labs Inc
- Porton Pharma Solutions Ltd
- Probiotec Ltd
- Prolytic GmbH
- Pronomz Ventures LLP
- PSC Biotech Corp
- QED Bioscience Inc
- Quadrants Scientific Inc
- Quality Packaging Specialists International LLC
- Quotient Sciences Ltd
- RA Chem Pharma Ltd
- Raichem Medicare Pvt Ltd
- Ramdev Chemicals Pvt Ltd
- Recipharm AB
- Rentschler Biopharma SE
- Rubicon Research Pvt Ltd
- Samco Gold Limited
- Sandoz Industrial Products SpA
- Sanofi
- Seikagaku Corp
- Selcia Ltd
- SGS SA
- Shandong Jincheng Pharmaceutical and Chemical Co Ltd
- Shandong Luoxin Pharmaceutical Group Stock Co Ltd
- Shanghai Ruiyi Investment Development Center
- Sharp Packaging Services
- Shilpa Medicare Ltd
- Shire Pharmaceuticals International UC
- SI Group Inc
- Siegfried Holding AG
- Signet Healthcare Partners
- SIX.02 Bioservices LLC
- SK Capital Partners LP
- SK Inc
- Solara Active Pharma Sciences Ltd
- Solvias AG
- SONEAS Chemicals Ltd
- Sorrento Therapeutics Inc
- Spectris Plc
- Spera Pharma Inc
- STA Pharmaceutical Co Ltd
- Stemline Therapeutics Inc
- Sterling Pharma Solutions Ltd
- Strides Chemicals Private Limited
- Strides Pharma Science Ltd
- SUANFARMA Italia SpA
- SuanFarma SA
- Symbiotec Pharmalab Ltd
- SYNLAB Analytics & Services Germany GmbH
- Synova Capital LLP
- Syntagon AB
- Tanabe Seiyaku Yoshiki Factory Co., Ltd.
- Tergus Pharma LLC
- Teva Pharmaceutical Industries Ltd
- Teva Takeda Pharma Ltd
- The Carlyle Group LP
- The EQT VIII fund
- Therapiva Pvt Ltd
- Tjoapack BV
- Torii Pharmaceutical Co Ltd
- TPG Growth LLC
- TriPharm Services Inc
- Tubilux Pharma SpA
- UI Gestion SA
- ValueAct Capital Management, L.P.
- Veeda Clinical Research Pvt Ltd
- VelaLabs GmbH
- Velesco Pharmaceutical Services LLC
- Veloxis Pharmaceuticals AS
- Vetter Pharma-Fertigung GmbH & Co KG
- Viatris Inc
- Vibalogics GmbH
- Vigene Biosciences Inc
- Viva Biotech Shanghai Ltd
- Vivimed Labs Spain SL
- Vivimed Life Sciences Pvt Ltd
- Wasdell Packaging Group
- Weifang Yaxing Chemical Co Ltd
- Windlas Biotech Pvt Ltd
- Windlas Healthcare Pvt Ltd
- WuXi AppTec Co Ltd
- WuXi Biologics Cayman Inc
- WuXi Pharmatech (Cayman) Inc
- Xiamen Kingdomway Group Co
- Zhejiang Better Pharmaceuticals Co Ltd
- Zhejiang Doyin Pump Industry Co., Ltd.
- Zhejiang Hisyn Pharmaceutical Co Ltd
- Zhejiang Jiuzhou Pharmaceutical Co Ltd
- Zhejiang Langhua Pharmaceutical Co Ltd
- Zhejiang Raybow Pharmaceutical Co Ltd
- Zhejiang Starry Pharmaceutical Co Ltd
- Zhejiang Sunflower Light Energy Science & Technology LLC
